Long-term results of a randomized study of intravesical instillation of epirubicin and doxorubicin as a prophylaxis against superficial bladder cancer recurrence

Nishinihon Journal of Urology

Volumn 59, Issue 11, 1997, Pages 785-791

  Gohji, Kazuo ^a   Hara, Isao ^a   Taguchi, Isao ^a   Ueno, Koichi ^a   Yamada, Yuji ^a   Eto, Hiroshi ^a   Arakawa, Soichi ^a   Kamidono, Sadao ^a   Obe, Satoshi ^b   Ogawa, Takayoshi ^c   Hamami, Gaku ^d   Yamanaka, Nozomu ^e  

^a KOBE UNIVERSITY   (Japan)

^b Akashi Municipal Hospital   (Japan)

^c HIMEJI RED CROSS HOSPITAL   (Japan)

^d Hyogo Prefectural Amagasaki Hospital   (Japan)

^e Shinko Hospital   (Japan)

Author keywords

Bladder cancer; Doxorubicin; Epirubicin; Intravesical instillation

Indexed keywords

DOXORUBICIN; EPIRUBICIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER INHIBITION; CANCER RECURRENCE; CANCER STAGING; DRUG EFFICACY; DYSURIA; FEMALE; FOLLOW UP; HEMATURIA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLLAKISURIA;

EID: 7844221013     PISSN: 00290726     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Lutzeyer, W. et al.: Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. J. Urol. 127: 250-254, 1982.
2. Torti, F. M. and Lum, B. L.: The biology and treatment of superficial bladder cancer. J. Clin. Oncol. 2: 505-531, 1984
3. Flamm, J.: Long-term versus short-term doxorubicin hydrochloride instillation after transurethral resection of superficial bladder cancer. Eur. Urol. 17: 119-124, 1990.
4. Batts, C. N.: Adjuvant intravesical therapy for superficial bladder cancer. Annals of Pharmacol 26: 1270-1276, 1992.
5. Tolley, D. A. et al.: The medical research council superficial bladder cancer working party The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow-up. J. Urol. 155: 1233-1238, 1996.
6. Bonfante, V. et al.: Toxic and therapeutic activity of 4-epi-doxorubicin. Tumori 68: 105-111, 1982.
7. Ganzina, F.: 4-Epi-doxorubicin: a preliminary overview of preclinical and clinical data. Cancer Treat. Rev. 10: 1-22, 1983.
8. Calais, da Silva, et al.: Intravesical chemoresection with 4'-epi-doxorubicin in patients with superficial bladder tumors. Eur. Urol 14: 207-209, 1988.
9. Matsumura, Y et al.: Intravesical chemotherapy with 4-epi-adriamycin in patients with superficial bladder tumors. Cancer Chemother. Pharmacol. 16: 176-177, 1986.
10. Koss, L. G.: Tumors of the urinary bladder. In Firminger, H. I.: Atlas of Tumor Pathology. Armed Forces Institute of Pathology, Washington DC, 2nd series fasc. 11, 1975.
11. Harmer, M. H.: TNM Classification of Malignant Tumours 3rd ed. International Union Against Cancer, Geneva, 1978.
12. Oosterlinck, W. et al.: A prospective European organization for research and treatment of cancer genitourinary group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder. J. Urol. 149: 749-752, 1993.
13. Melekos, M. D.: Prophylaxis of superficial bladder cancer with a modified intravesical epirubicin treatment schedule. Oncology 50: 450-455, 1993.
14. Pavone-Macaluso, M. et al.: Current views on intravesical treatment and chemoprophylaxis of superficial bladder cancer. The present role of epirubicin and doxorubicin. J. Chemother. 5: 207-211, 1993.
15. Noda, M. et al.: Postoperative adjuvant chemotherapy by early intravesical instillations of epirubicin for the treatment of superficial bladder cancer. Nishinihon J. Urol. 55: 43-45, 1993.
16. Akaza, H., BCG and bladder cancer-future direction of BCG treatment. Annal BCG and BRM Immunotherapy 19: 1-10, 1995.
17. Herr, H. W. et al.: Superficial bladder cancer treated with Bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression. J. Urol. 141: 22-29, 1989.
18. Brosman, S. A.: The use of Bacillus Calmette-Guerin in the therapy of bladder carcinoma in situ. J. Urol. 134: 36-39, 1985.
19. Melekos, M. D. et al.: Intravesical 4'-epi-doxorubicin (epi-rubicin) versus Bacillus Calmette-Guerin. A controlled prospective study on the prophylaxis of superficial bladder cancer. Cancer 72: 1749- 1755, 1993.